Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Deborah Wexler MD, MSc
Deborah J. Wexler MD, MSc Associate Editor
Silvio Inzucchi MD
Silvio E. Inzucchi MD Editor-in-Chief
Richard Pratley MD
Richard E. Pratley MD Associate Editor
See All Experts
featured
Published in Diabetes

Expert Opinion / Interview · July 02, 2018

ADA 2018: Sequencing Injectable Therapies in Type 2 Diabetes

Jason Sloane MD
Interview by
Jason Sloane MD
John (Jack) Leahy MD

 

 Save  Recommend
 Share

Further Reading

Related Videos